Brief: Rovi H1 Net Profit Down At 44.3 Mln Euros YoY

Laboratorios Farmaceuticos Rovi

31/07/2024 06:37

July 31 (Reuters) - Laboratorios Farmaceuticos ROVI SA
 ROVI.MC :
    * H1 NET SALES 329.3 MILLION EUROS VERSUS 380.8 MILLION
EUROS YEAR
AGO
    * H1 NET PROFIT 44.3 MILLION EUROS VERSUS 66.6 MILLION EUROS
YEAR
AGO
    * H1 EBITDA 69.9 MILLION EUROS VERSUS 97.1 MILLION EUROS
YEAR AGO
    * BY 2024, CO EXPECTS ITS OPERATING INCOME TO DECREASE IN
THE
MID-RANGE OF THE FIRST TEN (I.E. THE TEN BETWEEN 0% AND 10%)
COMPARED TO 2023

Source text for Eikon:  ID:nCNM4qBNzl 
Further company coverage:  ROVI.MC 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))